AVITA Medical, Inc. (RCEL)
4.33
-0.05
(-1.14%)
USD |
NASDAQ |
May 13, 10:25
AVITA Medical Cash from Investing (Quarterly) : -0.019M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -1.077M |
| Perspective Therapeutics, Inc. | -109.55M |
| Twist Bioscience Corp. | -12.71M |
| Elutia, Inc. | 79.58M |
| TriSalus Life Sciences, Inc. | -0.041M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.474M |
| Cash from Financing (Quarterly) | 0.2169M |
| Free Cash Flow | -32.88M |
| Free Cash Flow Per Share (Quarterly) | -0.1596 |
| Free Cash Flow to Equity (Quarterly) | -6.124M |
| Free Cash Flow to Firm (Quarterly) | -3.601M |
| Free Cash Flow Yield | -27.27% |